This company doesn't seem to have many, or any, doctors on its management team. It also doesn't explain in any detail how their research builds upon or complements the rest of the world's understanding of hair follicle biology. What relation does FNDS have to DHT? How does a treatment that delivers vitamins to follicles combat Alopecia Areata, an auto-immune disease? How did a doctor specializing in mesotherapy stumble upon a cure for a disease affecting one of the most complex organs in the human body?
Something's "off" about this. Once again, it makes no sense for a company with a completed, working product (that they've replicated 30,000 times and administered to 5,000 people) to just stop everything - reformulate the product in China, of all places - and then seek a 5-10 year American approval process.
Why not seek approval in South America (where it has apparently been used to great effect) and China (where the product is created) concurrently with the United States? What happens when the FDA inevitably screws your company and delays market approval for the greater part of the next decade? What happens when Chinese corporations steal your IP? When was the last time anyone on your entire management team conducted a full clinical trial?
The fact that they're already selling stock and looking into fancy licensing deals puts them right up there with Replicel in terms of credibility, especially with all of these insane strategic business decisions.
I'd love to hear that I'm wrong and I'd love for Dr. Ziering to offer TBT another interview (his last one was very open and comprehensive), but I won't hold my breath.
Something's "off" about this. Once again, it makes no sense for a company with a completed, working product (that they've replicated 30,000 times and administered to 5,000 people) to just stop everything - reformulate the product in China, of all places - and then seek a 5-10 year American approval process.
Why not seek approval in South America (where it has apparently been used to great effect) and China (where the product is created) concurrently with the United States? What happens when the FDA inevitably screws your company and delays market approval for the greater part of the next decade? What happens when Chinese corporations steal your IP? When was the last time anyone on your entire management team conducted a full clinical trial?
The fact that they're already selling stock and looking into fancy licensing deals puts them right up there with Replicel in terms of credibility, especially with all of these insane strategic business decisions.
I'd love to hear that I'm wrong and I'd love for Dr. Ziering to offer TBT another interview (his last one was very open and comprehensive), but I won't hold my breath.
Comment